Related by context. All words. (Click for frequent words.) 66 talactoferrin 66 CCX# 65 Cetrorelix 65 alvespimycin 65 elotuzumab 65 Civacir 65 CR# vcMMAE 65 INCB# [001] 65 ALN VSP 64 huC# DM4 64 CMV vaccine 64 Sym# 64 HGS ETR1 64 FOLOTYN ® 64 pradefovir 64 Plicera 64 HuLuc# 64 Diamyd ® 64 OncoVEX GM CSF 64 Cethromycin 64 Phenoptin 64 Aurexis 64 forodesine 64 Anthim 64 Traficet EN 64 MGCD# [001] 64 Virulizin ® 64 torezolid phosphate 64 oral prodrug 63 AEG# 63 Archexin 63 Fibrillex TM 63 PXD# 63 CoFactor 63 Allovectin 7 R 63 telbivudine 63 MyVax R 63 BCX# 63 Veronate 63 DXL# 63 Azedra 63 ALN TTR# 63 lintuzumab 63 Phase Ib study 63 phase IIb clinical 63 HuMax CD4 63 ularitide 63 PRT# 63 MYDICAR ® 63 SparVax TM 63 Telbivudine 63 otelixizumab 63 R#/MEM # 63 pralatrexate 63 CEQ# 63 XmAb# 63 Phase Ib 63 SEBIVO 63 AzaSite Plus 63 TBC# 63 MAGE A3 ASCI 63 Phase 2a trial 62 HCD# [002] 62 Fodosine 62 AVN# [001] 62 Alocrest 62 SAR# [004] 62 PEG PAL 62 UPLYSO 62 Tarvacin TM 62 AP# [003] 62 Omacetaxine 62 valopicitabine 62 NEUMUNE 62 HEPLISAV 62 teduglutide 62 JAK inhibitor 62 Amigal 62 OvaRex ® MAb 62 GAP #B# 62 ATL# [001] 62 TELINTRA 62 Dapagliflozin 62 EOquin 62 TYZEKA 62 Panzem R 62 Virulizin R 62 Insegia 62 ALN TTR 62 Personalized Immunotherapy 62 maribavir 62 TOCOSOL Paclitaxel 62 RDEA# 62 Golimumab 62 PEG Interferon lambda 62 MAXY alpha 62 Exherin TM 62 HCV protease inhibitor 62 PEG SN# 62 anticancer compound 62 oral ridaforolimus 62 DOS# 62 Icatibant 62 MYDICAR 62 HGS ETR2 62 PDE4 inhibitor 61 GATTEX TM 61 GALNS 61 IMA# 61 methylnaltrexone 61 Tyzeka Sebivo 61 Proxinium TM 61 #D#C# 61 tezampanel 61 mapatumumab 61 AZX# 61 AzaSite TM 61 Triolex 61 LEP ETU 61 bardoxolone 61 calcineurin inhibitors 61 Azedra TM 61 SNT MC# 61 danoprevir 61 IDX# 61 HepeX B 61 KNS # 61 refractory gout 61 Allovectin 7 ® 61 ProLindac 61 ALN PCS 61 phase IIa clinical 61 eltrombopag 61 Xanafide 61 Nanobody 61 XL# XL# 61 GLP toxicology studies 61 S/GSK# 61 cannabinor 61 Alzhemed TM 61 HspE7 61 mertansine 61 OMNARIS HFA 61 Bronchitol 61 albinterferon alfa 2b 61 NXL# 61 ganetespib 61 IMGN# 61 FOLOTYN 61 relapsed multiple myeloma 61 Tarvacin 61 systemically administered 61 registrational 61 forodesine hydrochloride 61 INCB# [003] 61 REP# 61 H#N# VLP vaccine 61 Stimuvax R 61 NGX# 61 Ramoplanin 61 nitazoxanide 61 MAXY G# 61 Valortim 61 PLK1 SNALP 61 phase IIb trial 61 prGCD 61 Panzem R NCD 61 Restanza 61 SILENOR TM 61 drug ISA# 61 Tezampanel 61 daclizumab 61 YONDELIS 61 TACI Ig 61 MOZOBIL 60 denufosol 60 L BLP# 60 LE SN# 60 Zerenex 60 compound INCB# 60 phase IIb 60 Aviptadil 60 OHR/AVR# 60 Phase III Pivotal 60 Phase #b/#a 60 HuMax CD# 60 entinostat 60 LymphoStat B 60 TransVax ™ 60 Perifosine 60 PROMACTA 60 Shigamabs ® 60 Clolar ® 60 OncoVEX 60 Cloretazine 60 TPI ASM8 60 OXi# 60 ENMD # 60 Panzem 60 MyVax ® 60 blinatumomab 60 Altastaph 60 ABILIFY ® 60 anidulafungin 60 valtorcitabine 60 synthetic retinoid 60 Ceflatonin 60 T Pred 60 ASONEP 60 Marqibo 60 Cethrin R 60 registrational trial 60 virus HCV protease inhibitor 60 Phase IIb clinical 60 LymphoStat B belimumab 60 Cloretazine ® 60 HuMax EGFr 60 elvucitabine 60 Valortim R 60 TELCYTA 60 OvaRex R 60 investigational monoclonal antibody 60 Darinaparsin 60 LC#m# 60 AVE# 60 voreloxin 60 Troxatyl 60 Heplisav 60 PNT# 60 chemotherapy induced neutropenia 60 Acetavance 60 HQK 60 trastuzumab DM1 T DM1 60 Dacogen injection 60 lumiliximab 60 elacytarabine 60 G#DT 60 Zolinza 60 CYT# 60 obatoclax 60 ORENCIA R 60 PrevOnco ™ 60 GRNVAC1 60 BLA filing 60 Symadex 60 ELND# 60 RNAi therapeutic targeting PCSK9 60 ponatinib 60 tgAAC# 60 pexiganan 60 XL# XL# XL# XL# 60 darapladib 60 BiovaxID TM 60 Phase IIa trial 60 CytoFab 60 APOPTONE 60 anti CD3 monoclonal 60 Annamycin 60 VivaGel TM 60 IL# PE#QQR 60 AQ4N 59 preclinical studies 59 Alinia 59 Bicifadine 59 ELACYT 59 PANVAC VF 59 Viramidine 59 Relivar 59 pegloticase 59 riociguat 59 orBec R 59 Sebivo 59 Phase 1b trial 59 Glufosfamide 59 hepatitis C HCV 59 Luteinizing Hormone Releasing Hormone 59 Onalta 59 PEGylated 59 RELOVAIR ™ 59 DEB# 59 Mipomersen 59 axitinib 59 Amrubicin 59 omega interferon 59 Aganocide 59 dose cohort 59 RAV# 59 ICA # 59 Leukine 59 Hepatitis C HCV 59 Protexia R 59 Relovair 59 Phase #b/#a trial 59 Velcade bortezomib 59 FluINsure 59 MBP# [001] 59 LibiGel ® 59 telaprevir VX 59 BENLYSTA ® 59 VitiGam 59 BZL# 59 Mycograb 59 Radezolid 59 velafermin 59 Carfilzomib 59 humanized anti 59 Kamada AAT 59 SPRYCEL ® 59 LEUKINE 59 cMET 59 Lupuzor 59 Pradefovir 59 BiTE antibody 59 LHRH antagonist 59 TRAIL receptor antibodies 59 GVAX ® 59 XL# [003] 59 dirucotide 59 PDX pralatrexate 59 omecamtiv mecarbil 59 BioVant 59 AOP Orphan 59 Bezielle 59 Vitaxin 59 MEK inhibitor 59 menadione 59 alvimopan 59 PS# [001] 59 HCV protease inhibitors 59 Pimavanserin 59 BioNumerik 59 TRO# 59 TMC# [002] 59 GRN# 59 INCB# [002] 59 NeuroVax TM 59 Nasulin 59 REOLYSIN ® 59 posaconazole 59 ONCONASE R 59 Azixa 59 ISTODAX 59 XL# anticancer compounds 59 ulimorelin 59 CDP# 59 nonclinical studies 59 C1 INH 59 Hedgehog antagonist 59 romidepsin 59 rPA anthrax vaccine 59 RPL# 59 ISIS # 59 Zemiva ™ 59 Onalta ™ 59 NP2 Enkephalin 59 oral methylnaltrexone 59 DAVANAT R 59 PSMA ADC 59 Locteron 59 custirsen 59 Actimmune ® 59 tolevamer 59 Pivotal Phase III 59 Androxal ® 59 CBLC# 59 faropenem 59 Phase 2b Clinical Trial 59 RGB # 59 EndoTAG TM -1 59 DermaVir Patch 59 adecatumumab 59 liposomal formulation 59 Vicriviroc 59 CIMZIA TM 59 Ridaforolimus 59 novel VDA molecule 59 Thiovir 59 tezampanel NGX# 59 TKM ApoB 59 mocetinostat 59 lenalidomide Revlimid R 59 Phase 2b clinical 59 TOCOSOL Camptothecin 59 cinacalcet HCl 59 IAP inhibitors 59 PHX# 59 Synavive 59 Cardio Vascu Grow 59 Reverset 59 docetaxel Taxotere R 59 CCR9 antagonist 59 non nucleoside HCV 59 Phase IIIb clinical 59 tafamidis 59 vidofludimus 59 Nanobody R 59 DAVANAT 59 Phase 2a 59 Phase III clinical trials 58 VLP vaccine 58 NVA# 58 docetaxel Taxotere ® 58 Vernakalant 58 GSK# [001] 58 lesinurad 58 confirmatory Phase 3 58 ESBA# 58 CA4P 58 Stimuvax 58 Phase 1b 58 ImmunoVEX HSV2 58 orally bioavailable 58 TREANDA 58 Chemophase 58 delivers fluocinolone acetonide FA 58 Androxal TM 58 polymerase inhibitor 58 tivozanib 58 Solazed 58 proteasome inhibitor 58 Clolar 58 CCR5 mAb 58 BAY #-# 58 #I TM# 58 volociximab 58 Ophena TM 58 RSD# 58 CINTREDEKIN BESUDOTOX 58 PNP inhibitor 58 therapeutic monoclonal antibody 58 nalbuphine ER 58 Crofelemer 58 glufosfamide 58 iSONEP 58 Cleviprex TM clevidipine 58 deforolimus 58 Iluvien ® 58 Pafuramidine 58 octreotide implant 58 rhC1INH 58 Laquinimod 58 selective androgen receptor modulator 58 leading oral taxane 58 ketolide antibiotic 58 CD# antibody [001] 58 ATL/TV# 58 eniluracil 58 Neuradiab 58 PRTX 58 Canvaxin TM 58 Trizytek 58 DCVax R 58 ZADAXIN ® 58 Chrysalin 58 Prednisporin 58 Romidepsin 58 Phase Ia 58 RhuDex ® 58 baminercept 58 esophageal candidiasis 58 TG# [003] 58 Allovectin 7 58 Raptiva ® 58 elesclomol 58 GRN#L 58 ruxolitinib 58 decitabine 58 investigational compound 58 TroVax 58 RNAi therapeutic 58 mTOR inhibition 58 Unit Dose Budesonide 58 bevirimat 58 crofelemer 58 Thiarabine 58 Daclizumab 58 Cytolin ® 58 cobiprostone 58 thymalfasin 58 polymerase inhibitors 58 Cancidas 58 iclaprim 58 Phase #/#a 58 TransVax TM 58 oral beclomethasone dipropionate 58 vascular disrupting agent 58 PREOS R 58 dacetuzumab 58 Oral NKTR 58 Mozobil 58 Genz # 58 amrubicin 58 UVIDEM 58 Atiprimod 58 phase Ib 58 Cannabinor 58 telomerase therapeutic 58 IMPDH inhibitor 58 ELADUR 58 ONCONASE 58 Palifosfamide 58 VAPRISOL 58 QLT# 58 StaphVAX R 58 romiplostim 58 SinuNase TM 58 PEGPH# 58 Onconase 58 EOquin TM 58 adenoviral 58 OMNARIS Nasal Spray 58 highly immunogenic 58 ARIKACE 58 BEXXAR 58 Interferon alpha 58 RLY# 58 Alnylam #x# 58 tiapamil 58 VivaGel ™ 58 oral picoplatin 58 Topical Interferon Alpha 2b 58 farletuzumab 58 chronic HCV infection 58 Technosphere Insulin 58 ongoing Phase 1b 58 velaglucerase alfa 58 pegylated interferons 58 BLA submission 58 Factor VIIa 58 RiVax 58 ANA# 58 Phase 1a clinical 58 favorable pharmacokinetic profile 58 SinuNase 58 Dasatinib 58 micafungin 58 Locteron ® 58 NV1FGF 58 Aplidin 58 hyperphenylalaninemia HPA due 58 Bortezomib 58 Solazed TM 58 cintredekin besudotox 58 EVIZON TM squalamine lactate 58 Spiegelmer ® 58 hoFH 58 atacicept 58 Hsp# Inhibitor 58 Aclidinium 58 Aurora kinase inhibitor 58 milatuzumab 58 daptomycin 58 IND enabling 58 Cethrin 58 DAVANAT ® 58 HGS ETR1 mapatumumab 58 delafloxacin 58 aleglitazar 58 Phase 2a clinical 58 Tavocept 58 PCK# 58 lixivaptan 58 catheter occlusion 58 vosaroxin 58 cancer immunotherapies 58 FTY# 58 PrevOnco 58 Loramyc R 58 Surfaxin LS 58 tanespimycin 58 veltuzumab 58 Zalbin 58 Dacogen decitabine 58 MLN# 58 AZILECT ® 58 Tolvaptan 58 TRANSDUR Sufentanil 58 Inhalation Solution 58 MNTX 58 A3 adenosine receptor 58 Fibrin Pad 58 Arikace 58 luliconazole 58 SNALP technology 58 hepatitis C virus HCV 58 CTAP# Capsules 58 orally administered inhibitor 58 PREOS 58 4CMenB 58 radiation sensitizer 57 Alfimeprase 57 Omigard 57 celgosivir 57 Stedivaze 57 pomalidomide 57 diarrhea predominant irritable 57 lucinactant 57 investigational humanized monoclonal antibody 57 ABRAXANE TM 57 vismodegib 57 Phase 2b study 57 pharmacokinetic interactions 57 tesetaxel 57 Ocrelizumab 57 humanized antibody 57 CG# [003] 57 StemEx R 57 AZD# 57 Cintredekin Besudotox 57 Tesetaxel 57 Amplimexon 57 JAK2 inhibitor 57 AeroLEF TM 57 TG# [001] 57 Japanese Encephalitis vaccine 57 cetuximab Erbitux ® 57 faropenem medoxomil 57 StemEx 57 CCX# B 57 Besivance 57 mGluR5 NAM 57 Mepact 57 Flutiform TM 57 Proellex TM 57 oral salmon calcitonin 57 Genasense ® oblimersen 57 PRX # 57 Generx TM 57 cell lymphoma CTCL 57 nucleoside analog 57 Tamibarotene 57 enzastaurin 57 IMP# 57 Rotarix ® 57 non nucleoside 57 ONTAK 57 LymphoStat B TM 57 Zemiva TM 57 LE DT 57 chronic HBV 57 Indaflex TM 57 oral proteasome inhibitor 57 ORENCIA ® 57 refractory chronic lymphocytic 57 Motesanib 57 Lixivaptan 57 Numax 57 Virulizin 57 Genasense ® 57 Phase 1b clinical 57 GAMMAGARD 57 MORAb 57 DexaSite 57 AzaSite 57 Voreloxin 57 ocrelizumab 57 INT# [002] 57 QVA# 57 EP #R 57 cilengitide 57 ApoB SNALP 57 PROVENGE sipuleucel T 57 Fibrillex 57 ataluren 57 Acute Radiation Syndrome ARS 57 relapsed MM 57 Tyrima 57 orBec 57 canakinumab 57 Achieves Primary Endpoint 57 Elotuzumab 57 Ophena 57 omacetaxine mepesuccinate 57 metaglidasen 57 Cloretazine R VNP#M 57 hypoxia activated prodrug 57 low dose cytarabine 57 dosing cohort 57 Phase Ib clinical 57 IRX 2 57 LB# [003] 57 cangrelor 57 MEK inhibitors 57 Pazopanib 57 Dalbavancin 57 BNC# 57 ceftaroline 57 X Excite 57 motavizumab 57 prostone 57 OMP #M# 57 Thalomid ® 57 thalidomide Thalomid 57 bortezomib Velcade 57 Epanova 57 Telatinib 57 Azedra ™ 57 PSN# [002] 57 Xcytrin R 57 Vaxfectin 57 Emselex 57 ospemifene 57 MKC# MT 57 JAK inhibitors 57 small molecule defensin 57 Allovectin 7 r 57 Kuvan R 57 oxymorphone ER 57 Satraplatin 57 Zingo TM 57 Trofex TM 57 Cerashield 57 CORT # 57 Clavis Pharma 57 TKM PLK1 57 Vidofludimus 57 pegylated interferon alfa 57 Cobalamin 57 Nexavar sorafenib 57 selective modulator 57 initiate Phase 1b 57 evaluating tivozanib 57 Viral Immunotherapy platform 57 Elagolix 57 Zelrix 57 Campath ® 57 Celgosivir 57 apricitabine 57 sorafenib Nexavar 57 aclidinium 57 HuCNS SC cells 57 talabostat 57 intranasal formulation 57 Phase 1a 57 CIMZIA ™ 57 TYGACIL 57 Vicinium TM 57 acetonide FA 57 MAA submission 57 raxibacumab 57 Asentar 57 forodesine HCl 57 Phase IIb clinical trials 57 Hepatitis C virus HCV 57 Phase IIb trials 57 Mylotarg 57 confirmatory clinical 57 FavId 57 phase IIa 57 Gemzar ® 57 HGS# 57 Belimumab 57 sunitinib malate 57 TLK# 57 pharmacokinetic PK study 57 glucokinase activator 57 CRLX# 57 IIa trial 57 budesonide foam 57 HepaGam B 57 successfully commercialize Iluvien 57 human C1 inhibitor 57 ganciclovir 57 Exelixis XL# 57 Fx #A 57 CCR5 antagonist 57 FluCide 57 recurrent genital herpes 57 R#/MEM 57 ProSavin 57 TAFA# 57 JAK3 57 DU #b 57 solithromycin 57 BiTE 57 phase IIb III 57 Aflibercept 57 GLYX 57 Exelixis compounds 57 rhMBL 57 MOVIPREP R 57 oritavancin 57 next generation URAT1 57 bardoxolone methyl 57 PEGylated Fab fragment 57 Actilon 57 DCVax R Brain 57 Excellagen 57 Behcet uveitis 57 CytoFabTM 57 ZALBIN 57 StaphVAX 57 VEGF receptor inhibitor 57 ocular formulation 57 administered subcutaneously 57 antibody MAb 57 Azilect ® 57 ceftazidime 57 drug GAP #B# 57 MERLIN TIMI 57 ACTEMRA TM 57 Phase IIa clinical 57 CYT# potent vascular disrupting 57 ofatumumab 57 alemtuzumab MS 57 VELCADE melphalan 57 Plenaxis TM 57 reslizumab 57 XP# XP# 57 lomitapide 57 antisense drug 57 TheraCIM 57 Investigational Treatment 57 Maribavir 57 HuMax TAC 57 Adentri 57 Zoraxel 57 ambrisentan 57 urocortin 2 57 MEK Inhibitor 57 pharmacokinetic PK 57 NS4A 57 Phase IIa 57 Guanilib 57 Lovaza TM 57 RH1 57 Begins Dosing 57 IV APAP 57 oral talactoferrin 57 GED aPC 57 RSD# oral 57 Vaprisol 57 clinical pharmacology studies 57 REPLAGAL 56 SILENOR 56 VA# [002] 56 IAP inhibitor 56 MGCD# [002] 56 EVIZON TM 56 Phase III clinical 56 eprotirome 56 Vandetanib 56 Phase IIb trial 56 Ceplene 56 product platforms AZX# 56 Pivotal Trial 56 Blinatumomab 56 REG1 Anticoagulation System 56 metastatic RCC 56 CYC# 56 BrachySil 56 5 HT3 antagonist 56 IND submission 56 REMUNE R 56 BRIM3 56 clinicaltrials 56 sodium glucose cotransporter 56 Methylnaltrexone 56 Zalypsis 56 TOLAMBA 56 Silodosin 56 Copegus ribavirin 56 2 methoxyestradiol 56 SEPET TM 56 pegylated interferon alfa 2a 56 CLORETAZINE TM VNP#M 56 Initiates Clinical 56 intravenous acetaminophen 56 IMC A# 56 rFIXFc 56 Vivecon 56 ROTARIX 56 adenosine injection 56 gastrointestinal stromal tumors GIST 56 Orapred ODT 56 AZILECT R 56 replicon 56 BrachySil TM 56 BHT DNA 56 elagolix 56 lintuzumab SGN 56 INTEGRILIN ® 56 DAS# [001] 56 Phase #b/#a clinical 56 picoplatin 56 Abbokinase 56 rilonacept 56 voclosporin 56 MVA BN R 56 Revimmune 56 Aptivus ® 56 ROTATEQ 56 INC# 56 Eraxis 56 APD# 56 CRD5 56 BiovaxID 56 MabCampath 56 acyclovir Lauriad R 56 darinaparsin 56 ADAGIO study 56 potent antiviral 56 Phase III Clinical Trial 56 bendamustine HCl 56 sapropterin dihydrochloride Tablets 56 neuraminidase inhibitor 56 Solazed ™ 56 preclinical pharmacokinetic 56 #ME# 56 Reolysin 56 ALTU 56 receptor tyrosine kinase inhibitor 56 PGL# 56 bendamustine 56 viral kinetics 56 regorafenib 56 squalamine 56 SUMAVEL 56 Phase Ib II 56 Phase IIa clinical trials 56 PRECISE trial 56 sapacitabine 56 LAF# 56 Alpharadin 56 oropharyngeal candidiasis 56 alagebrium 56 Ampligen R 56 reduce serum phosphate 56 CB2 selective receptor agonist 56 cardio renal 56 neratinib 56 dalbavancin 56 Serdaxin 56 Prednisporin TM 56 Meets Primary Endpoint 56 generation purine nucleoside 56 JAK1 56 Talactoferrin 56 pegylated 56 CCR5 inhibitors 56 pafuramidine 56 Leukine ® 56 OMAPRO 56 VIR# 56 Omacetaxine mepesuccinate 56 rBChE 56 Corlux 56 peginesatide 56 DepoBupivacaine TM 56 sumatriptan DosePro 56 EDEMA3 56 Shigamabs R 56 AzaSite Xtra 56 Apoptone 56 defensin mimetic antibiotic 56 radezolid 56 Ozarelix 56 amphotericin B 56 NEUPOGEN 56 SUTENT 56 ostarine 56 BARACLUDE R 56 inhaled liposomal ciprofloxacin 56 standard chemotherapy regimen 56 Staphylococcus aureus Polysaccharide Conjugate 56 Menerba 56 Aloxi injection 56 Sphingomab 56 Gleevec resistant 56 CTA# Injection 56 Pralatrexate 56 Neo Kidney Augment 56 aflibercept 56 Sapacitabine 56 Telavancin 56 orally dosed 56 PI3K/Akt pathway inhibitor 56 Potelligent Technology 56 immatics 56 novel synthetic PEGylated 56 VitiGam TM 56 investigational antiplatelet agent 56 Albuferon TM 56 vernakalant oral 56 pegfilgrastim 56 RNAi therapeutic targeting 56 APTIVUS r 56 Pirfenidone 56 Diamyd R 56 THR beta agonist 56 ZOLINZA 56 phase III isavuconazole 56 ancrod 56 bevacizumab Avastin ® 56 torezolid 56 Octreolin 56 Enobia 56 TTR gene 56 protease inhibitor telaprevir